{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T12:10:40Z","timestamp":1753877440179,"version":"3.41.2"},"reference-count":22,"publisher":"Oxford University Press (OUP)","issue":"8","license":[{"start":{"date-parts":[[2021,6,17]],"date-time":"2021-06-17T00:00:00Z","timestamp":1623888000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,8,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>To achieve global hepatitis C virus (HCV) eradication, barriers prohibiting treatment access need to be overcome. We established a strategy to initiate antiviral therapy in patients with severe, refractory heroin addiction. All patients achieved sustained virological response. Outreach programs of hepatologists might be a reasonable way to overcome barriers to HCV treatment.<\/jats:p>","DOI":"10.1093\/ofid\/ofab325","type":"journal-article","created":{"date-parts":[[2021,6,17]],"date-time":"2021-06-17T23:19:45Z","timestamp":1623971985000},"source":"Crossref","is-referenced-by-count":2,"title":["Reaching the Unreachable: Strategies for HCV Eradication in Patients With Refractory Opioid Addiction\u2014A Real-world Experience"],"prefix":"10.1093","volume":"8","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4425-2640","authenticated-orcid":false,"given":"Lisa","family":"Sandmann","sequence":"first","affiliation":[{"name":"Department of Gastroenterology, Hepatology and Endocrinology, Hannover Medical School, Hannover, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julian","family":"Deppe","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, Social Psychiatry and Psychotherapy, Hannover Medical School, Hannover, Germany"},{"name":"Patrida Medizinisches Versorgungszentrum, Hannover, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christoph","family":"Beier","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Hepatology and Endocrinology, Hannover Medical School, Hannover, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valerie","family":"Ohlendorf","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Hepatology and Endocrinology, Hannover Medical School, Hannover, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julia","family":"Schneider","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Hepatology and Endocrinology, Hannover Medical School, Hannover, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heiner","family":"Wedemeyer","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Hepatology and Endocrinology, Hannover Medical School, Hannover, Germany"},{"name":"German Center for Infection Research (DZIF), Partner Site Hannover-Braunschweig, Hannover, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Felix","family":"Wedeg\u00e4rtner","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, Social Psychiatry and Psychotherapy, Hannover Medical School, Hannover, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Markus","family":"Cornberg","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Hepatology and Endocrinology, Hannover Medical School, Hannover, Germany"},{"name":"German Center for Infection Research (DZIF), Partner Site Hannover-Braunschweig, Hannover, Germany"},{"name":"Centre for Individualised Infection Medicine (CiiM), Helmholtz Centre for Infection Research, Hannover, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benjamin","family":"Maasoumy","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Hepatology and Endocrinology, Hannover Medical School, Hannover, Germany"},{"name":"German Center for Infection Research (DZIF), Partner Site Hannover-Braunschweig, Hannover, Germany"},{"name":"Centre for Individualised Infection Medicine (CiiM), Helmholtz Centre for Infection Research, Hannover, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2021,6,17]]},"reference":[{"year":"2016","author":"World Health Organization.","key":"2021080504402721800_CIT0001"},{"key":"2021080504402721800_CIT0002","doi-asserted-by":"crossref","first-page":"e1192","DOI":"10.1016\/S2214-109X(17)30375-3","article-title":"Global prevalence of injecting drug use and sociodemographic characteristics and prevalence of HIV, HBV, and HCV in people who inject drugs: a multistage systematic review","volume":"5","author":"Degenhardt","year":"2017","journal-title":"Lancet Glob Health"},{"key":"2021080504402721800_CIT0003","doi-asserted-by":"crossref","first-page":"424","DOI":"10.3389\/fpubh.2020.00424","article-title":"Prevalence of hepatitis B, C, and D in Germany: results from a scoping review","volume":"8","author":"Sperle","year":"2020","journal-title":"Front Public Health"},{"key":"2021080504402721800_CIT0004","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofaa317","article-title":"Clinical and patient-reported outcomes of direct-acting antivirals for the treatment of chronic hepatitis C among patients on opioid agonist treatment: a real-world prospective cohort study","volume":"7","author":"Schulte","year":"2020","journal-title":"Open Forum Infect Dis"},{"key":"2021080504402721800_CIT0005","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1111\/add.14128","article-title":"Direct-acting antiviral treatment of chronic HCV-infected patients on opioid substitution therapy: still a concern in clinical practice?","volume":"113","author":"Christensen","year":"2018","journal-title":"Addiction"},{"key":"2021080504402721800_CIT0006","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.jhep.2019.02.018","article-title":"Response to direct-acting antiviral therapy among ongoing drug users and people receiving opioid substitution therapy","volume":"71","author":"Mac\u00edas","year":"2019","journal-title":"J Hepatol"},{"key":"2021080504402721800_CIT0007","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1093\/cid\/ciy899","article-title":"Integrated, co-located, telemedicine-based treatment approaches for hepatitis C virus management in opioid use disorder patients on methadone","volume":"69","author":"Talal","year":"2019","journal-title":"Clin Infect Dis"},{"key":"2021080504402721800_CIT0008","doi-asserted-by":"crossref","first-page":"625","DOI":"10.7326\/M16-0816","article-title":"Elbasvir-grazoprevir to treat hepatitis C virus infection in persons receiving opioid agonist therapy: a randomized trial","volume":"165","author":"Dore","year":"2016","journal-title":"Ann Intern Med"},{"key":"2021080504402721800_CIT0009","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1093\/cid\/civ396","article-title":"Long-term treatment outcomes of patients infected with hepatitis C virus: a systematic review and meta-analysis of the survival benefit of achieving a sustained virological response","volume":"61","author":"Simmons","year":"2015","journal-title":"Clin Infect Dis"},{"key":"2021080504402721800_CIT0010","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1002\/hep.26431","article-title":"Hepatitis C virus treatment for prevention among people who inject drugs: modeling treatment scale-up in the age of direct-acting antivirals","volume":"58","author":"Martin","year":"2013","journal-title":"Hepatology"},{"key":"2021080504402721800_CIT0011","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s12954-019-0316-4","article-title":"Introducing hepatitis C virus healthcare pathways in addiction care in the Netherlands with a breakthrough project: a mixed method study","volume":"16","author":"Kracht","year":"2019","journal-title":"Harm Reduct J"},{"key":"2021080504402721800_CIT0012","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1111\/jvh.13119","article-title":"Perceived barriers related to testing, management and treatment of HCV infection among physicians prescribing opioid agonist therapy: the C-SCOPE study","volume":"26","author":"Litwin","year":"2019","journal-title":"J Viral Hepat"},{"key":"2021080504402721800_CIT0013","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/j.jhep.2019.04.016","article-title":"Patient-reported symptoms during and after direct-acting antiviral therapies for chronic hepatitis C: the PROP UP study","volume":"71","author":"Evon","year":"2019","journal-title":"J Hepatol"},{"key":"2021080504402721800_CIT0014","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1002\/hep.20659","article-title":"Impact of hepatitis C on health related quality of life: a systematic review and quantitative assessment","volume":"41","author":"Spiegel","year":"2005","journal-title":"Hepatology"},{"key":"2021080504402721800_CIT0015","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.drugalcdep.2010.01.009","article-title":"Successful treatment of chronic hepatitis C virus infection in severely opioid-dependent patients under heroin maintenance","volume":"109","author":"Schulte","year":"2010","journal-title":"Drug Alcohol Depend"},{"key":"2021080504402721800_CIT0016","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S2468-1253(17)30404-1","article-title":"Sofosbuvir and velpatasvir for hepatitis C virus infection in people with recent injection drug use (SIMPLIFY): an open-label, single-arm, phase 4, multicentre trial","volume":"3","author":"Grebely","year":"2018","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"2021080504402721800_CIT0017","doi-asserted-by":"crossref","first-page":"594","DOI":"10.7326\/M18-1715","article-title":"Intensive models of hepatitis C care for people who inject drugs receiving opioid agonist therapy: a randomized controlled trial","volume":"170","author":"Akiyama","year":"2019","journal-title":"Ann Intern Med"},{"key":"2021080504402721800_CIT0018","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1111\/jvh.13378","article-title":"Life after hepatitis C cure in HIV-infected people who inject drugs and men who have sex with men treated with direct-acting antivirals in France: health perceptions and experiences from qualitative and quantitative findings (ANRS CO13 HEPAVIH)","volume":"27","author":"Mora","year":"2020","journal-title":"J Viral Hepat"},{"journal-title":"J Viral Hepat","article-title":"Only partial improvement in health-related quality of life after treatment of chronic hepatitis C virus infection with direct acting antivirals in a real-world setting-results from the German Hepatitis C-Registry (DHC-R)","author":"Ohlendorf","key":"2021080504402721800_CIT0019"},{"key":"2021080504402721800_CIT0020","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/j.jhep.2018.07.025","article-title":"Hepatitis C virus reinfection after successful treatment with direct-acting antiviral therapy in a large population-based cohort","volume":"69","author":"Rossi","year":"2018","journal-title":"J Hepatol"},{"key":"2021080504402721800_CIT0021","doi-asserted-by":"crossref","first-page":"e96","DOI":"10.1016\/S2352-3018(20)30301-5","article-title":"HCV micro-elimination in individuals with HIV in the Netherlands 4 years after universal access to direct-acting antivirals: a retrospective cohort study","volume":"8","author":"Smit","year":"2021","journal-title":"Lancet HIV"},{"key":"2021080504402721800_CIT0022","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.drugalcdep.2018.06.013","article-title":"\u2018Hep C\u2019s like the common cold\u2019: understanding barriers along the HCV care continuum among young people who inject drugs","volume":"190","author":"Skeer","year":"2018","journal-title":"Drug Alcohol Depend"}],"container-title":["Open Forum Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ofid\/advance-article-pdf\/doi\/10.1093\/ofid\/ofab325\/38684562\/ofab325.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/ofid\/article-pdf\/8\/8\/ofab325\/39570849\/ofab325.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/ofid\/article-pdf\/8\/8\/ofab325\/39570849\/ofab325.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,5]],"date-time":"2021-08-05T04:41:01Z","timestamp":1628138461000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ofid\/article\/doi\/10.1093\/ofid\/ofab325\/6303541"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,17]]},"references-count":22,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2021,8,1]]}},"URL":"https:\/\/doi.org\/10.1093\/ofid\/ofab325","relation":{},"ISSN":["2328-8957"],"issn-type":[{"type":"electronic","value":"2328-8957"}],"subject":[],"published-other":{"date-parts":[[2021,8,1]]},"published":{"date-parts":[[2021,6,17]]},"article-number":"ofab325"}}